Lupin to make equity investment in Sunsure Solarpark

11 Sep 2024 Evaluate

Lupin has signed Share Subscription & Shareholders agreement with Sunsure Solarpark Seventeen (Sunsure Solarpark) and Sunsure Energy (Sunsure) to make equity investment in Sunsure Solarpark. The objective of investment is to purchase renewable power through open access for the Company’s Tarapur manufacturing site. In addition to saving on power costs, the acquisition would enable the Company to fulfill its commitments on decarbonization. 

Upto 42.61% of equity share capital of Sunsure Solarpark to be acquired at a total consideration not exceeding Rs 10.55 crore, to be completed in two tranches, in the capacity as a Captive User.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2128.40 -26.85 (-1.25%)
15-Jan-2025 15:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1755.00
Dr. Reddys Lab 1339.95
Cipla 1446.75
Lupin 2128.40
Zydus Lifesciences 984.15
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.